Skip to main content
. 2019 Jul 24;10(7):247–255. doi: 10.5306/wjco.v10.i7.247

Figure 2.

Figure 2

Posttreatment PD-L1 expression pattern in our patients’ high grade serous ovarian carcinoma and in tumor infiltrating lymphocytes. A: Tumor cell with strong positive membranous staining of PD-L1; B: Tumor with artificial membranous and some cytoplasmatic staining of PD-L1 as well as some immune cells with PD-L1 expression; C: For comparison: an example of PD-L1 staining in immune cells.